Live feed
·
PRReleasevia Quantisnow
PMV Pharmaceuticals Inc. logo

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
PMVP· PMV Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PMVP (PMV Pharmaceuticals Inc.) and more on Quantisnow.